MGC Diagnostics (MGCD) Declares $0.70 Special Dividend; 9.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
MGC Diagnostics Corporation Declares $0.70 Per Share Special Cash Dividend and Retains Investment Banking Firm to Explore Strategic Options
January 25, 2017 4:03 PM ESTSAINT PAUL, Minn., Jan. 25, 2017 /PRNewswire/ -- MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, announced today that its Board of Directors approved a special cash dividend of $0.70 per share on its outstanding common stock. The cash dividend will be payable on February 24, 2017 to all shareholders of record as of February 10, 2017.
MGC Diagnostics Corporation Chairman Mark Sheffert stated, "The Board of Directors has approved a special cash dividend, demonstrating our commitment to enhancing shareholder value. This special dividend is the result of our confidence in the Company's... More
